Cargando…

Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study

OBJECTIVE: To compare the mortality rates of patients with claudication and de novo femoropopliteal lesions treated with and without paclitaxel coated devices (PCD). BACKGROUND: A recent meta-analysis, mostly including patients with claudication and de novo femoropopliteal lesions but also with recu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gahide, Gérald, Phaneuf, Samuel C., Cossette, Mathilde, Banine, Amine, Budimir, Martina, Maghsoudloo, Kourosh, Fei, Phillip, Dou, Bo Yi, Bouthillier, Maxime, Alain, Charles, Bradette, Simon, Noel-Lamy, Maxime, Belzile, Francois, Bui, Bao The, Despatis, Marc Antoine, Vendrell, Jean Francois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382808/ https://www.ncbi.nlm.nih.gov/pubmed/34424424 http://dx.doi.org/10.1186/s42155-021-00255-1

Ejemplares similares

Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease
por: Naiem, Ahmed A, et al.
Publicado: (2021)

Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Algorithm of Femoropopliteal Endovascular Treatment
por: Dubosq, Maxime, et al.
Publicado: (2022)

Combination of Rotational Atherothrombectomy and Paclitaxel-Coated Angioplasty for Femoropopliteal Occlusion
por: Scheer, F, et al.
Publicado: (2015)

Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019)

A Budget Impact Model for Paclitaxel-eluting Stent in Femoropopliteal Disease in France
por: De Cock, Erwin, et al.
Publicado: (2012)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency()
por: Marples, Rory, et al.
Publicado: (2021)

Safety of paclitaxel-coated devices in the femoropopliteal arteries: A systematic review and meta-analysis
por: Zhang, Chenyang, et al.
Publicado: (2022)

Claudication
por: Walder, D. N.
Publicado: (1969)

Intermittent Claudication
Publicado: (1908)

Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics
por: Du, Xin, et al.
Publicado: (2019)

Genome-wide association mapping of Sclerotinia sclerotiorum resistance in soybean using whole-genome resequencing data
por: Boudhrioua, Chiheb, et al.
Publicado: (2020)

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
por: Müller-Hülsbeck, Stefan, et al.
Publicado: (2016)

Assessment of Mortality and Factors Affecting Outcome of Use of Paclitaxel-Coated Stents and Bare Metal Stents in Femoropopliteal PAD
por: Falkowski, Aleksander, et al.
Publicado: (2020)

Causes Of Claudication In Children
por: Pinheiro, Ana Costa, et al.
Publicado: (2018)

Paclitaxel exposure: Long‐term safety and effectiveness of a drug‐coated balloon for claudication in pooled randomized trials
por: Schneider, Peter A., et al.
Publicado: (2020)

Exercise prescription using the heart of claudication pain onset in patients with intermittent claudication
por: Cucato, Gabriel Grizzo, et al.
Publicado: (2013)

Diabetes mellitus and intermittent claudication: a cross-sectional study of 920 claudicants
por: Lozano, Francisco S, et al.
Publicado: (2014)

The Edinburgh Claudication Questionnaire has poor diagnostic accuracy in people with intermittent claudication
por: Ibeggazene, Saïd, et al.
Publicado: (2022)

Fast-GBS: a new pipeline for the efficient and highly accurate calling of SNPs from genotyping-by-sequencing data
por: Torkamaneh, Davoud, et al.
Publicado: (2017)

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
por: Dake, Michael D., et al.
Publicado: (2016)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

3D-GBS: a universal genotyping-by-sequencing approach for genomic selection and other high-throughput low-cost applications in species with small to medium-sized genomes
por: de Ronne, Maxime, et al.
Publicado: (2023)

COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions
por: Steiner, Sabine, et al.
Publicado: (2020)

Calcified nodule progression-related stent thrombosis after polymer-based paclitaxel-eluting nitinol stent implantation for femoropopliteal artery
por: Nakama, Tatsuya, et al.
Publicado: (2020)

Long‐term outcomes after paclitaxel‐coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study
por: Ko, Young‐Guk, et al.
Publicado: (2022)

The Effect of Severe Femoropopliteal Arterial Calcification on the Treatment Outcome of Femoropopliteal Intervention in Patients with Ischemic Tissue Loss
por: Lee, Hyun Yong, et al.
Publicado: (2020)

Intermittent Claudication in Hypertensive Men
por: Ramsay, L. E.
Publicado: (1979)

Infographic. Exercise for intermittent claudication
por: Tew, Garry A, et al.
Publicado: (2020)

Intermittent Claudication in Physiotherapists' Practice
por: Spannbauer, Anna, et al.
Publicado: (2019)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Optimization of in vitro and ex vitro Agrobacterium rhizogenes-mediated hairy root transformation of soybean for visual screening of transformants using RUBY
por: Niazian, Mohsen, et al.
Publicado: (2023)

Pontomedullary junction as a reference for spinal cord cross-sectional area: validation across neck positions
por: Bédard, Sandrine, et al.
Publicado: (2023)

One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2020)

Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
por: Kichikawa, Kimihiko, et al.
Publicado: (2018)

Refractory Vascular Wall Healing after Paclitaxel-Coated Nitinol Stent Implantation in the Femoropopliteal Artery: A High-Resolution Angioscopic Assessment
por: Ikeoka, Kuniyasu, et al.
Publicado: (2018)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
por: Teichgräber, Ulf, et al.
Publicado: (2021)

Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication
por: Kruidenier, Lotte M, et al.
Publicado: (2009)

An Infrarenal Aortic Hypoplasia Presented with Claudication
por: Sung, Su-Ah, et al.
Publicado: (2010)

Quality of life in patients with intermittent claudication
por: Harwood, A. E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rgg3rrt9fi9p249ve9563qt5rp